SynthesisBMC nephrology2024

Cardio-renal protective effect and safety of sodium-glucose cotransporter 2 inhibitors for chronic kidney disease patients with eGFR < 60 mL/min/1.73 m2: a systematic review and meta-analysis.

Yaru Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.